Form 8-K/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

 

FORM 8-K/A

 

 

(Amendment No. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 11, 2011

 

 

OPKO Health, Inc.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Delaware   001-33528   75-2402409

(State or Other

Jurisdiction of

Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

4400 Biscayne Blvd Miami, Florida   33137
Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (305) 575-4100

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


EXPLANATORY NOTE

OPKO Health, Inc. (the “Company”) is filing this Amendment No. 1 to its Current Report on Form 8-K that was initially filed with the Securities and Exchange Commission on October 12, 2011 to file the pro forma financial information required by Item 9.01 of Form 8-K with respect to the Company’s disposition of its ophthalmic instrumentation business to Optos plc.

 

ITEM 9.01. Financial Statements and Exhibits

 

(b) Pro Forma Financial Information.

The following pro forma financial information is being filed with this report as Exhibit 99.1:

 

   

Unaudited Pro Forma Condensed Consolidated Balance Sheet as of June 30, 2011

 

   

Unaudited Pro Forma Condensed Consolidated Statement of Operations for the six months ended June 30, 2011

 

   

Unaudited Pro Forma Condensed Consolidated Statement of Operations for the year ended December 31, 2010

 

(d) Exhibits

 

Exhibit Number    Description
99.1    Pro Forma Financial Information listed in Item 9.01(b)


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

OPKO Health, Inc.

By

  /s/ Rao Uppaluri
Name:   Rao Uppaluri
Title:   Senior Vice President, Chief Financial Officer

Date November 14, 2011


Exhibit Index

 

Exhibit Number    Description
99.1    Pro Forma Financial Information listed in Item 9.01(b)